Related Experiment Videos
Involvement of lipoxygenases in the activation of mouse macrophages by endotoxin
Abstract:
Preincubation with lipopolysaccharides stimulated the phagocytic capacity of mouse peritoneal macrophages. Treatment of cell cultures with inhibitors of lipoxygenases which affect this pathway specifically (diethylcarbamazine) or compounds which block lipoxygenases and cyclooxygenase (BW 755 C, eicosatetraynoic acid) inhibited the increase, while inhibitors of cyclooxygenase (indomethacin, aspirin) did not affect the LPS induced enhancement of the phagocytic capacity. It is, therefore, concluded that lipoxygenase products are required for the activation of macrophages by endotoxins.
Insights
Lipopolysaccharides (LPS) enhance macrophage phagocytosis, a process dependent on lipoxygenase pathways. Inhibiting lipoxygenase blocked this LPS-induced enhancement, indicating its crucial role in endotoxin activation of macrophages.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Macrophages are key immune cells involved in phagocytosis.
- Lipopolysaccharides (LPS) are potent stimulators of innate immune responses.
- Lipoxygenase and cyclooxygenase pathways are critical in inflammatory mediator production.
Purpose of the Study:
- To investigate the role of lipoxygenase and cyclooxygenase pathways in LPS-induced macrophage activation.
- To determine if lipoxygenase products are necessary for enhanced phagocytic capacity.
Main Methods:
- Mouse peritoneal macrophages were preincubated with LPS.
- Cells were treated with specific inhibitors of lipoxygenase (diethylcarbamazine) and cyclooxygenase (indomethacin, aspirin).
- Combined inhibitors of both pathways (BW 755 C, eicosatetraynoic acid) were also used.
- Phagocytic capacity was measured after treatments.
Main Results:
- LPS preincubation significantly increased macrophage phagocytic capacity.
- Inhibitors of lipoxygenase, including combined pathway inhibitors, blocked the LPS-induced enhancement.
- Inhibitors of cyclooxygenase alone did not affect the LPS-induced enhancement.
Conclusions:
- Lipoxygenase products are essential for the activation of macrophage phagocytic capacity by LPS.
- Endotoxin-induced macrophage activation is critically dependent on the lipoxygenase pathway.